Name | Value |
---|---|
Revenues | 44.2M |
Cost of Revenue | 29.8M |
Gross Profit | 14.4M |
Operating Expense | 57.3M |
Operating I/L | -42.9M |
Other Income/Expense | -0.2M |
Interest Income | 1.5M |
Pretax | -43.5M |
Income Tax Expense | 0.2M |
Net Income/Loss | -43.7M |
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in genomics and proteomics. Its flagship product, the nCounter Analysis System, is an automated digital detection and counting system used for various applications. The company also offers nCounter MAX and FLEX systems, nCounter SPRINT Profiler, nSolver Analysis Software, custom CodeSets, panels with various applications, Master Kits, and Prosigna molecular diagnostic test kits. Additionally, NanoString is developing the GeoMx DSP system for spatial genomics. The company generates revenue through the sale of these systems, software, and molecular diagnostic test kits, as well as through collaborations with other companies for research and development projects.